Table 1 Criteria for diagnosis of metabolic syndrome
From: Prevalence of metabolic syndrome and its components in Iran: an updated meta-analysis
Components | NCEP ATP III | WHO | AHA/NHLBI | IDF | JIS | Iranian criteria |
|---|---|---|---|---|---|---|
Criteria | ≥ 3 of the components below | Insulin resistance or diabetes, plus ≥ 2 of the five criteria below | ≥ 3 of the components | Obesity plus ≥ 2 of the four criteria below | ≥ 3 of the components below | ≥ 3 of the components below |
Obesity | Waist Circumference: ≥ 102 cm for men, ≥ 88 cm for women | Waist/hip ratio > 0.9 for men, > 0.85 for women or BMI > 30 | Waist Circumference: ≥ 102 cm for men, ≥ 88 cm for women | Waist Circumference: ≥ 94 cm for men, ≥ 80 cm for women, or BMI > 30 | Waist Circumference: ≥ 94 cm for men, ≥ 80 cm for women, or BMI > 30 | Waist Circumference in both genders ≥ 95 cm |
Fasting Glucose | ≥ 100 mg/dL (≥ 5.6 mmol/L) | Insulin resistance is already required ≥ 110 mg/dL (≥ 6.1 mmol/L) | ≥ 100 mg/dL (≥ 5.6 mmol/L) or receiving medication | ≥ 100 mg/dL (≥ 5.6 mmol/L) or receiving medication | ≥ 100 mg/dL (≥ 5.6 mmol/L) or receiving medication | ≥ 100 mg/dL (≥ 5.6 mmol/L) or receiving medication |
Blood Pressure | > 130 mmHg systolic or > 85 mmHg diastolic | ≥ 140/90 mmHg | > 130 mmHg systolic or > 85 mmHg diastolic or receiving medication | > 130 mmHg systolic or > 85 mmHg diastolic or receiving medication | > 130 mmHg systolic or > 85 mmHg diastolic or receiving medication | > 130 mmHg systolic or > 85 mmHg diastolic or receiving medication |
Triglycerides | ≥ 150 mg/dL (1.7 mmol/L) | ≥ 150 mg/dL (1.7 mmol/L) | ≥ 150 mg/dL (1.7 mmol/L) or receiving medication | ≥ 150 mg/dL (1.7 mmol/L) or receiving medication | ≥ 150 mg/dL (1.7 mmol/L) or receiving medication | ≥ 150 mg/dL (1.7 mmol/L) or receiving medication |
HDL Cholesterol | < 40 mg/dL (1.03 mmol/L) in men, < 50 mg/dL (1.29 mmol/L) in women | < 35 mg/dL (mmol/L) in men, < 39 mg/dL (mmol/L) in women | < 40 mg/dL (1.03 mmol/L) in men, < 50 mg/dL (1.29 mmol/L) in women or receiving medication | < 40 mg/dL (1.03 mmol/L) in men, < 50 mg/dL (1.29 mmol/L) in women or receiving medication | < 40 mg/dL (1.03 mmol/L) in men, < 50 mg/dL (1.29 mmol/L) in women or receiving medication | < 40 mg/dL (1.03 mmol/L) in men, < 50 mg/dL (1.29 mmol/L) in women or receiving medication |